RenovoRx, Inc. (RNXT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.66−$0.0200 (−1.19%) on the dayAs of the close; data may be delayed.
RNXT price, last 12 months
Key stats
- Previous close
- $1.68
- Open
- $1.62
- Day range
- $1.62 – $1.73
- 52-week range
- $0.7006 – $2.59
- Volume
- 480.9K
- Avg volume (20 days)
- 1.5M
- Market cap
- $74.9M
Performance
1W−1.8%
1M+11.4%
3M+75.9%
6M+43.1%
YTD+97.6%
1Y+38.3%
vs S&P 500, 1Y+21.6 pts
Technicals and fundamentals
About RenovoRx, Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $74.9M